Presentation slides and video from the 2021-2022 Advances in Cancer Immunotherapy™: A Focus on Toxicity Management held in Houston, TX and virtually on April 28, 2022 are available here.Program Organizers
Program Summary
Specifically designed by the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, nurse practitioners, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) programs are half-day innovative programs will have the opportunity for in-depth training in immunotherapy treatment for a variety of topics from leaders in this specific field. The ACI program also featured a discussion of closed cases submitted from attendees to hear guidance and insights from expert faculty.
Program Learning Objectives
Please note on-demand recordings are not available for continuing education credits.#AdvancesinCancerImmunotherapy(ACI)#2022 #ClinicalTrials#PresentationSlides#Video
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on Toxicity Management; Presenter: Maen Abdelrahim, MD, PhD, PharmD – Houston Methodist; Noha Abdel-Wahab, MD, PhD – The University of Texas MD Anderson Cancer Center; Mehmet Altan, MD – The University of Texas MD Anderson Cancer Center; Adi Diab, MD – The University of Texas MD Anderson Cancer Center; Nicolas Palaskas, MD – The University of Texas MD Anderson Cancer Center; Michelle Rohlfs, APRN, FNP-BC, AOCNP – The University of Texas MD Anderson Cancer Center; Sumit Subudhi, MD, PhD – The University of Texas MD Anderson Cancer Center; Van Anh Trinh, PharmD, BCOP – The University of Texas MD Anderson Cancer Center; Yinghong (Mimi) Wang, MD, PhD, MS – The University of Texas MD Anderson Cancer Center; Jennifer A. Wargo, MD, MMSc – The University of Texas MD Anderson Cancer Center; Date: April 28, 202200:30:28
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on Toxicity Management; Presenter: Michelle Rohlfs, APRN, FNP-BC, AOCNP – The University of Texas MD Anderson Cancer Center; Date: April 28, 202200:25:41
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on Toxicity Management; Presenter: Van Anh Trinh, PharmD, BCOP – The University of Texas MD Anderson Cancer Center; Date: April 28, 202200:02:18
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on Toxicity Management; Presenter: Adi Diab, MD – The University of Texas MD Anderson Cancer Center; Date: April 28, 202200:25:41
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on Toxicity Management; Presenter: Jennifer A. Wargo, MD, MMSc – The University of Texas MD Anderson Cancer Center; Date: April 28, 202200:25:27
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on Toxicity Management; Presenter: Noha Abdel-Wahab, MD, PhD – The University of Texas MD Anderson Cancer Center; Date: April 28, 202200:23:56
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on Toxicity Management; Presenter: Maen Abdelrahim, MD, PhD, PharmD – Houston Methodist; Date: April 28, 202200:28:55
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on Toxicity Management; Presenter: Yinghong (Mimi) Wang, MD, PhD, MSc – The University of Texas MD Anderson Cancer Center; Date: April 28, 202200:17:10
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on Toxicity Management; Presenter: Nicolas L. Palaskas, MD – The University of Texas MD Anderson Cancer Center; Date: April 28, 202200:22:11
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on Toxicity Management; Presenter: Mehmet Altan, MD – The University of Texas MD Anderson Cancer Center; Date: April 28, 202200:18:07
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on Toxicity Management; Presenter: Sumit Subudhi, MD, PhD – The University of Texas MD Anderson Cancer Center; Date: April 28, 202200:17:12
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us